Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
-0.200 (-6.71%)
At close: Jun 27, 2025, 4:00 PM
2.920
+0.140 (5.04%)
After-hours: Jun 27, 2025, 7:10 PM EDT

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
107152326112206262
Market Cap Growth
-13.03%-53.41%191.65%-45.72%-21.31%-
Enterprise Value
7387229193--
Last Close Price
2.784.009.139.9810.0812.81
PS Ratio
36.0657.64118.2431.67-263.6045.94
PB Ratio
6.324.614.802.13-10.4290.02
P/TBV Ratio
6.324.614.802.13--
EV/Sales Ratio
25.3232.9782.9654.51--
Debt / Equity Ratio
0.980.500.030.23-0.293.25
Asset Turnover
0.040.030.030.07--
Inventory Turnover
1.711.280.881.232.91-
Quick Ratio
3.234.137.824.520.902.50
Current Ratio
3.354.277.954.560.932.52
Return on Equity (ROE)
-179.12%-120.84%-81.47%-205.22%--
Return on Assets (ROA)
-60.70%-46.90%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-93.36%-67.42%-48.00%-81.16%--
Earnings Yield
-62.26%-40.13%-15.05%-30.04%-11.16%-8.15%
FCF Yield
-51.13%-33.44%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-6.17%-10.82%-121.67%-609.97%-4.86%-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q